Clinical Trial

Biomarkers for Endometriosis

Recruiting
View on ClinicalTrials.gov →
Summary
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-08-04
Trial Details
NCT Number NCT07713797
Lead Sponsor Trio Fertility
Conditions Endometriosis
Enrollment 100 participants
Start Date 2026-01-16
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-03